<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Bisphosphonate,Bisphosphonates,Bisphosphonates,ATC code M05,Adenosine triphosphate,Alendronate,Alendronic acid,Apoptosis,Bone mineral density,Bone resorption,Bone tissue" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Bisphosphonate - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Bisphosphonate</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <p>In <a href="../../../p/h/a/Pharmacology.html" title="Pharmacology">pharmacology</a>, <b>bisphosphonates</b> (also called: <b>diphosphonates</b>) is a class of drugs that inhibits the <a href="../../../b/o/n/Bone_resorption.html" title="Bone resorption">resorption of bone</a>. Its uses include the prevention and treatment of <a href="../../../o/s/t/Osteoporosis.html" title="Osteoporosis">osteoporosis</a>, <a href="../../../o/s/t/Osteitis_deformans.html" title="Osteitis deformans">osteitis deformans</a> ("Paget's disease of bone"), bone <a href="../../../m/e/t/Metastasis.html" title="Metastasis">metastasis</a> (with or without <a href="../../../h/y/p/Hypercalcemia.html" title="Hypercalcemia">hypercalcemia</a>), <a href="../../../m/u/l/Multiple_myeloma.html" title="Multiple myeloma">multiple myeloma</a> and other conditions that feature bone fragility.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#Chemistry_and_classes"><span class="tocnumber">2</span> <span class="toctext">Chemistry and classes</span></a></li>
<li class="toclevel-1"><a href="#Pharmacokinetics"><span class="tocnumber">3</span> <span class="toctext">Pharmacokinetics</span></a></li>
<li class="toclevel-1"><a href="#Mechanism_of_action"><span class="tocnumber">4</span> <span class="toctext">Mechanism of action</span></a>
<ul>
<li class="toclevel-2"><a href="#Non-nitrogenous"><span class="tocnumber">4.1</span> <span class="toctext">Non-nitrogenous</span></a></li>
<li class="toclevel-2"><a href="#Nitrogenous"><span class="tocnumber">4.2</span> <span class="toctext">Nitrogenous</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Uses"><span class="tocnumber">5</span> <span class="toctext">Uses</span></a></li>
<li class="toclevel-1"><a href="#Side-effects"><span class="tocnumber">6</span> <span class="toctext">Side-effects</span></a></li>
<li class="toclevel-1"><a href="#Footnotes"><span class="tocnumber">7</span> <span class="toctext">Footnotes</span></a></li>
<li class="toclevel-1"><a href="#External_Links"><span class="tocnumber">8</span> <span class="toctext">External Links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/s/Bisphosphonate.html" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>Bisphosphonates were developed in the 19th century, but were first investigated in the 1960s for use in disorders of bone metabolism. Their non-medical use included water softening in irrigation systems used in orange groves. The initial rationale for their use in humans was their potential in preventing the dissolution of <a href="../../../h/y/d/Hydroxylapatite.html" title="Hydroxylapatite">hydroxylapatite</a>, the principal bone mineral, and hence arresting bone loss. Only in the 1990s was their actual mechanism of action demonstrated.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[1]</a></sup></p>
<p><a name="Chemistry_and_classes" id="Chemistry_and_classes"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/s/Bisphosphonate.html" title="Edit section: Chemistry and classes">edit</a>]</span> <span class="mw-headline">Chemistry and classes</span></h2>
<p>All bisphosphonate drugs share a common P-C-P "backbone":</p>
<p><a href="../../../b/i/s/Image%7EBisphosphonate_basic_structure.png_099b.html" class="image" title="basic structure of bisphosphonates"><img src="../../../upload/d/d2/Bisphosphonate_basic_structure.png" alt="basic structure of bisphosphonates" width="227" height="145" longdesc="../../../b/i/s/Image%7EBisphosphonate_basic_structure.png_099b.html" /></a></p>
<p>The two PO<sub>3</sub> (<a href="../../../p/h/o/Phosphate.html" title="Phosphate">phosphate</a>) groups <a href="../../../c/o/v/Covalent.html" title="Covalent">covalently</a> linked to <a href="../../../c/a/r/Carbon.html" title="Carbon">carbon</a> determine both the name "bis<i>phospho</i>nate" and the function of the drugs.</p>
<p>The long <i><a href="../../../s/i/d/Side_chain.html" title="Side chain">side chain</a></i> (<b>R<sub>2</sub></b> in the diagram) determines the chemical properties, the mode of action and the strength of bisphosphonate drugs. The short <i>side chain</i> (R<sub>1</sub>), often called the 'hook,' mainly influences chemical properties and <a href="../../../p/h/a/Pharmacokinetics.html" title="Pharmacokinetics">pharmacokinetics</a>.</p>
<p><a name="Pharmacokinetics" id="Pharmacokinetics"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/s/Bisphosphonate.html" title="Edit section: Pharmacokinetics">edit</a>]</span> <span class="mw-headline">Pharmacokinetics</span></h2>
<p>Of the bisphosphonate that is resorbed (from oral preparation) or infused (for <a href="../../../i/n/t/Intravenous.html" title="Intravenous">intravenous</a> drugs), about 50% is excreted unchanged by the kidney. The remainder has a very high affinity for <a href="../../../b/o/n/Bone_tissue.html" title="Bone tissue">bone tissue</a>, and is rapidly absorbed onto the bone surface.</p>
<p><a name="Mechanism_of_action" id="Mechanism_of_action"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/s/Bisphosphonate.html" title="Edit section: Mechanism of action">edit</a>]</span> <span class="mw-headline">Mechanism of action</span></h2>
<p>Bisphosphonates, when attached to bone tissue, are "ingested" by <a href="../../../o/s/t/Osteoclast.html" title="Osteoclast">osteoclasts</a>, the bone cell that breaks down bone tissue.</p>
<p>There are two classes of <i>bisphosphonate</i>: the <i><a href="../../../n/i/t/Nitrogen.html" title="Nitrogen">N</a></i>-containing and non-<i>N</i>-containing bisphosphonates. The two types of bisphosphonates work differently in killing osteoclast cells.</p>
<div class="floatright"><span><a href="../../../b/i/s/Image%7EBisphosphonate_side_chains.png_33d2.html" class="image" title="side chains of bisphosphonate molecules"><img src="../../../upload/thumb/b/b5/Bisphosphonate_side_chains.png/350px-Bisphosphonate_side_chains.png" alt="side chains of bisphosphonate molecules" width="350" height="307" longdesc="../../../b/i/s/Image%7EBisphosphonate_side_chains.png_33d2.html" /></a></span></div>
<p><a name="Non-nitrogenous" id="Non-nitrogenous"></a></p>
<h3><span class="editsection">[<a href="../../../b/i/s/Bisphosphonate.html" title="Edit section: Non-nitrogenous">edit</a>]</span> <span class="mw-headline">Non-nitrogenous</span></h3>
<p>Non-<i>N</i>-containing bisphosphonates:</p>
<ul>
<li><a href="../../../e/t/i/Etidronic_acid.html" title="Etidronic acid">Etidronate</a> (Didronel®) - 1 (potency relative to that of etidronate)</li>
<li>Clodronate (Bonefos®, Loron®) - 10</li>
<li>Tiludronate (Skelid®) - 10</li>
</ul>
<p>The non-nitrogenous bisphosphonates are <a href="../../../m/e/t/Metabolism.html" title="Metabolism">metabolised</a> in the <a href="../../../c/e/l/Cell_%28biology%29.html" title="Cell (biology)">cell</a> to compounds that compete with <a href="../../../a/d/e/Adenosine_triphosphate.html" title="Adenosine triphosphate">adenosine triphosphate</a> (ATP) in the cellular energy metabolism. The osteoclast initiates <a href="../../../a/p/o/Apoptosis.html" title="Apoptosis">apoptosis</a> and dies, leading to an overall decrease in the breakdown of bone.<sup id="_ref-1" class="reference"><a href="#_note-1" title="">[2]</a></sup></p>
<p><a name="Nitrogenous" id="Nitrogenous"></a></p>
<h3><span class="editsection">[<a href="../../../b/i/s/Bisphosphonate.html" title="Edit section: Nitrogenous">edit</a>]</span> <span class="mw-headline">Nitrogenous</span></h3>
<p><i>N</i>-containing bisphosphonates:</p>
<ul>
<li><a href="../../../p/a/m/Pamidronate.html" title="Pamidronate">Pamidronate</a> (APD, Aredia®) - 100</li>
<li>Neridronate - 100</li>
<li>Olpadronate - 500</li>
<li><a href="../../../a/l/e/Alendronate.html" title="Alendronate">Alendronate</a> (Fosamax®) - 500</li>
<li><a href="../../../i/b/a/Ibandronate.html" title="Ibandronate">Ibandronate</a> (Bondronat®) - 1000</li>
<li><a href="../../../r/i/s/Risedronate.html" title="Risedronate">Risedronate</a> (Actonel®) - 2000</li>
<li><a href="../../../z/o/l/Zoledronate.html" title="Zoledronate">Zoledronate</a> (Zometa®) - 10000</li>
</ul>
<p>Nitrogenous bisphosphonates act on bone metabolism by binding and blocking the enzyme farnesyl diphosphate synthase (FPPS) in the <a href="../../../h/m/g/HMG-CoA_reductase_pathway_d53c.html" title="HMG-CoA reductase pathway">HMG-CoA reductase pathway</a> (also known as the mevalonate pathway).<sup id="_ref-2" class="reference"><a href="#_note-2" title="">[3]</a></sup></p>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="../../../h/m/g/Image%7EHMG-CoA_reductase_pathway.png_8690.html" class="internal" title="HMG-CoA reductase pathway"><img src="../../../upload/shared/thumb/3/39/HMG-CoA_reductase_pathway.png/180px-HMG-CoA_reductase_pathway.png" alt="HMG-CoA reductase pathway" width="180" height="234" longdesc="../../../h/m/g/Image%7EHMG-CoA_reductase_pathway.png_8690.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../h/m/g/Image%7EHMG-CoA_reductase_pathway.png_8690.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
HMG-CoA reductase pathway</div>
</div>
</div>
<p>Disruption of the HMG CoA-reductase pathway at the level of FPPS prevents the formation of two metabolites (<a href="../../../f/a/r/Farnesol.html" title="Farnesol">farnesol</a> and geranylgeraniol) that are essential for connecting some small proteins to the <a href="../../../c/e/l/Cell_membrane.html" title="Cell membrane">cell membrane</a>. This phenomenon is known as prenylation, and is important for proper sub-cellular protein trafficking (see "<i><a href="../../../l/i/p/Lipid_anchored_protein.html" title="Lipid anchored protein">lipid anchored protein</a></i>" for the principles of this phenomenon).<sup id="_ref-3" class="reference"><a href="#_note-3" title="">[4]</a></sup></p>
<p>While inhibition of protein prenylation may affect many proteins found in an <a href="../../../o/s/t/Osteoclast.html" title="Osteoclast">osteoclast</a>, disruption to the lipid modification of <a href="../../../r/a/s/Ras.html" title="Ras">Ras</a>, <a href="../../../r/h/o/Rho.html" title="Rho">Rho</a>, <a href="../../../r/a/c/Rac.html" title="Rac">Rac</a> proteins has been speculated to underlie the effects of bisphosphonates. These proteins can affect both osteoclastogenesis, cell survival, and cytoskeletal dynamics. In particular, the cytoskeleton is vital for maintaining the "ruffled border" that is required for contact between a resorbing osteoclast and a bone surface.</p>
<p><a href="../../../s/t/a/Statin.html" title="Statin">Statins</a> are another class of drugs that inhibit the HMG-CoA reductase pathway. Unlike bisphosphonates, statins do not bind to bone surfaces with high affinity, and are thus not specific for bone. Nevertheless, some studies have reported a decreased rate of <a href="../../../f/r/a/Fracture_%28bone%29.html" title="Fracture (bone)">fracture</a> (an indicator of <a href="../../../o/s/t/Osteoporosis.html" title="Osteoporosis">osteoporosis</a>) and/or an increased <a href="../../../b/o/n/Bone_mineral_density.html" title="Bone mineral density">bone mineral density</a> in statin users. The overall efficacy of statins in the treatment osteoporosis remains controversial.</p>
<p><a name="Uses" id="Uses"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/s/Bisphosphonate.html" title="Edit section: Uses">edit</a>]</span> <span class="mw-headline">Uses</span></h2>
<p>Bisphosphonates are used clinically for the treatment of <a href="../../../o/s/t/Osteoporosis.html" title="Osteoporosis">osteoporosis</a>, <a href="../../../o/s/t/Osteitis_deformans.html" title="Osteitis deformans">osteitis deformans</a> (Paget's disease of the bone), bone <a href="../../../m/e/t/Metastasis.html" title="Metastasis">metastasis</a> (with or without <a href="../../../h/y/p/Hypercalcemia.html" title="Hypercalcemia">hypercalcemia</a>), <a href="../../../m/u/l/Multiple_myeloma.html" title="Multiple myeloma">multiple myeloma</a> and other conditions that feature bone fragility.</p>
<p>In osteoporosis and Paget's, alendronate and risedronate are the most popular first-line drugs. If these are ineffective or the patient develops digestive tract problems, intravenous pamidronate may be used. Alternatively, <a href="../../../s/t/r/Strontium_ranelate.html" title="Strontium ranelate">strontium ranelate</a> or <a href="../../../t/e/r/Teriparatide.html" title="Teriparatide">teriparatide</a> are used for refractory disease, and the SERM <a href="../../../r/a/l/Raloxifene.html" title="Raloxifene">raloxifene</a> is occasionally administered in postmenopausal women instead of bisphosphonates.</p>
<p>High-potency intravenous bisphosphonates have shown to modify progression of skeletal metastasis in several forms of cancer, especially <a href="../../../b/r/e/Breast_cancer.html" title="Breast cancer">breast cancer</a>.</p>
<p>More recently, bisphosphonates have been used to reduce fracture rates in children with <a href="../../../o/s/t/Osteogenesis_imperfecta.html" title="Osteogenesis imperfecta">osteogenesis imperfecta</a>.</p>
<p><a name="Side-effects" id="Side-effects"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/s/Bisphosphonate.html" title="Edit section: Side-effects">edit</a>]</span> <span class="mw-headline">Side-effects</span></h2>
<ul>
<li>Oral bisphosphonates can give <a href="../../../s/t/o/Stomach.html" title="Stomach">stomach</a> upset and <a href="../../../e/s/o/Esophagitis.html" title="Esophagitis">inflammation</a> and erosions of the <a href="../../../e/s/o/Esophagus.html" title="Esophagus">esophagus</a>, which is the main problem of oral <i>N</i>-containing preparations. This can be prevented by remaining seated upright for 30 to 60 minutes after taking the medication.</li>
<li>Intravenous bisphosphonates can give fever and flu-like symptoms after the first infusion, which is thought to occur because of their potential to activate human <a href="../../../g/a/m/Gamma_delta_T_cells_13c2.html" title="Gamma/delta T cells">γδ T cells</a>. Notably, these symptoms do not recur with subsequent infusions.</li>
<li>There is a slightly increased risk for <a href="../../../e/l/e/Electrolyte.html" title="Electrolyte">electrolyte</a> disturbances, but not enough to warrant regular monitoring.</li>
<li>In <a href="../../../c/h/r/Chronic_renal_failure.html" title="Chronic renal failure">chronic renal failure</a>, the drugs are excreted much slower, and dose adjustment is required.</li>
<li>Bisphosphonates have been associated with <a href="../../../o/s/t/Osteonecrosis_of_the_jaw.html" title="Osteonecrosis of the jaw">osteonecrosis of the jaw</a>; with the mandible twice as frequently affected as the maxilla and most cases occurring following high-dose intravenous administration used for some cancer patients. Some 60% of cases are preceded by a dental surgical procedure and it has been suggested that bisphosphonate treatment should be postponed until after any dental work to eliminate potential sites of infection.<sup id="_ref-4" class="reference"><a href="#_note-4" title="">[5]</a></sup></li>
<li>A number of cases of severe bone, joint or musculoskeletal pain have been reported, prompting labeling changes<sup id="_ref-5" class="reference"><a href="#_note-5" title="">[6]</a></sup></li>
</ul>
<p><a name="Footnotes" id="Footnotes"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/s/Bisphosphonate.html" title="Edit section: Footnotes">edit</a>]</span> <span class="mw-headline">Footnotes</span></h2>
<div class="references-small">
<ol class="references">
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> <cite style="font-style:normal">Fleisch H (2002). "Development of bisphosphonates.". <i>Breast Cancer Res</i> <b>4</b> (1): 30-4. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11879557" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11879557">PMID 11879557</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Development+of+bisphosphonates.&amp;rft.title=Breast+Cancer+Res&amp;rft.jtitle=Breast+Cancer+Res&amp;rft.date=2002&amp;rft.volume=4&amp;rft.issue=1&amp;rft.au=Fleisch+H&amp;rft.pages=30-4">&#160;</span></li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> <cite style="font-style:normal">Frith J, Mönkkönen J, Blackburn G, Russell R, Rogers M (1997). "Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro.". <i>J Bone Miner Res</i> <b>12</b> (9): 1358-67. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9286751" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9286751">PMID 9286751</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Clodronate+and+liposome-encapsulated+clodronate+are+metabolized+to+a+toxic+ATP+analog%2C+adenosine+5%27-%28beta%2C+gamma-dichloromethylene%29+triphosphate%2C+by+mammalian+cells+in+vitro.&amp;rft.title=J+Bone+Miner+Res&amp;rft.jtitle=J+Bone+Miner+Res&amp;rft.date=1997&amp;rft.volume=12&amp;rft.issue=9&amp;rft.au=Frith+J%2C+M%C3%B6nkk%C3%B6nen+J%2C+Blackburn+G%2C+Russell+R%2C+Rogers+M&amp;rft.pages=1358-67">&#160;</span></li>
<li id="_note-2"><b><a href="#_ref-2" title="">^</a></b> <cite style="font-style:normal">van Beek E, Cohen L, Leroy I, Ebetino F, Löwik C, Papapoulos S (Nov 2003). "Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates.". <i>Bone</i> <b>33</b> (5): 805-11. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14623056" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14623056">PMID 14623056</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Differentiating+the+mechanisms+of+antiresorptive+action+of+nitrogen+containing+bisphosphonates.&amp;rft.title=Bone&amp;rft.jtitle=Bone&amp;rft.date=2003&amp;rft.volume=33&amp;rft.issue=5&amp;rft.au=van+Beek+E%2C+Cohen+L%2C+Leroy+I%2C+Ebetino+F%2C+L%C3%B6wik+C%2C+Papapoulos+S&amp;rft.pages=805-11">&#160;</span></li>
<li id="_note-3"><b><a href="#_ref-3" title="">^</a></b> <cite style="font-style:normal">van beek E, Löwik C, van der Pluijm G, Papapoulos S (1999). "The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates.". <i>J Bone Miner Res</i> <b>14</b> (5): 722-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10320520" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10320520">PMID 10320520</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+role+of+geranylgeranylation+in+bone+resorption+and+its+suppression+by+bisphosphonates+in+fetal+bone+explants+in+vitro%3A+A+clue+to+the+mechanism+of+action+of+nitrogen-containing+bisphosphonates.&amp;rft.title=J+Bone+Miner+Res&amp;rft.jtitle=J+Bone+Miner+Res&amp;rft.date=1999&amp;rft.volume=14&amp;rft.issue=5&amp;rft.au=van+beek+E%2C+L%C3%B6wik+C%2C+van+der+Pluijm+G%2C+Papapoulos+S&amp;rft.pages=722-9">&#160;</span></li>
<li id="_note-4"><b><a href="#_ref-4" title="">^</a></b> <cite style="font-style:normal">Woo S, Hellstein J, Kalmar J (2006). "Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.". <i>Ann Intern Med</i> <b>144</b> (10): 753-61. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16702591" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16702591">PMID 16702591</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Narrative+%5Bcorrected%5D+review%3A+bisphosphonates+and+osteonecrosis+of+the+jaws.&amp;rft.title=Ann+Intern+Med&amp;rft.jtitle=Ann+Intern+Med&amp;rft.date=2006&amp;rft.volume=144&amp;rft.issue=10&amp;rft.au=Woo+S%2C+Hellstein+J%2C+Kalmar+J&amp;rft.pages=753-61">&#160;</span></li>
<li id="_note-5"><b><a href="#_ref-5" title="">^</a></b> <cite style="font-style:normal">Wysowski D, Chang J (2005). "Alendronate and risedronate: reports of severe bone, joint, and muscle pain.". <i>Arch Intern Med</i> <b>165</b> (3): 346-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15710802" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15710802">PMID 15710802</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Alendronate+and+risedronate%3A+reports+of+severe+bone%2C+joint%2C+and+muscle+pain.&amp;rft.title=Arch+Intern+Med&amp;rft.jtitle=Arch+Intern+Med&amp;rft.date=2005&amp;rft.volume=165&amp;rft.issue=3&amp;rft.au=Wysowski+D%2C+Chang+J&amp;rft.pages=346-7">&#160;</span></li>
</ol>
</div>
<p><a name="External_Links" id="External_Links"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/s/Bisphosphonate.html" title="Edit section: External Links">edit</a>]</span> <span class="mw-headline">External Links</span></h2>
<ul>
<li><a href="http://www.myeloma.org/main.jsp?source=link&amp;source_link_id=945&amp;type=article&amp;tab_id=13&amp;menu_id=94&amp;id=1165" class="external text" title="http://www.myeloma.org/main.jsp?source=link&amp;source_link_id=945&amp;type=article&amp;tab_id=13&amp;menu_id=94&amp;id=1165" rel="nofollow">International Myeloma Foundation article on bisphosphonates</a></li>
</ul>
<div class="NavFrame" style="clear:both;">
<div class="NavHead" style="background:#ccccff;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; position:absolute; width:auto; left:0.5em;"><a href="../../../b/i/s/Template%7EBisphosphonates_1e7e.html" title="Template:Bisphosphonates"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<span style="color: #002bb8;" title="Discussion about this template">d</span>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../b/i/s/Template%7EBisphosphonates_1e7e.html" class="external text" title="http://en.wikipedia.org../../../b/i/s/Template%7EBisphosphonates_1e7e.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
<b><strong class="selflink">Bisphosphonates</strong> (<a href="../../../a/t/c/ATC_code_M05_6bcd.html#M05BA_Bisphosphonates" title="ATC code M05">M05A</a>)</b></div>
<div class="NavContent" style="margin:0.5em; font-size:0.9em;">
<p><b><a href="../../../n/i/t/Nitrogen.html" title="Nitrogen">Nitrogenous</a>:</b> <a href="../../../p/a/m/Pamidronic_acid.html" title="Pamidronic acid">Pamidronic acid</a>, <a href="../../../a/l/e/Alendronic_acid.html" title="Alendronic acid">Alendronic acid</a>, <a href="../../../i/b/a/Ibandronic_acid.html" title="Ibandronic acid">Ibandronic acid</a>, <a href="../../../r/i/s/Risedronic_acid.html" title="Risedronic acid">Risedronic acid</a>, <a href="../../../z/o/l/Zoledronic_acid.html" title="Zoledronic acid">Zoledronic acid</a></p>
<p><b>Non-nitrogenous:</b> <a href="../../../e/t/i/Etidronic_acid.html" title="Etidronic acid">Etidronic acid</a>, Clodronic acid, Tiludronic acid</p>
</div>
</div>

<!-- 
Pre-expand include size: 33049 bytes
Post-expand include size: 15911 bytes
Template argument size: 8797 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../b/i/s/Bisphosphonate.html">http://en.wikipedia.org../../../b/i/s/Bisphosphonate.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Category</a>: <span dir='ltr'><a href="../../../b/i/s/Category%7EBisphosphonates_3ab2.html" title="Category:Bisphosphonates">Bisphosphonates</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../b/i/s/Bisphosphonate.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../b/i/s/Talk%7EBisphosphonate_d4fe.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Bisphosphonate">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/b/i/s/Bisphosphonat.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../it/b/i/f/Bifosfonati.html">Italiano</a>
	      </li>
	      	      <li>
	      <a href="../../../../pl/b/i/s/Bisfosfoniany.html">Polski</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 23:55, 18 March 2007 by Wikipedia user <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>. Based on work by Wikipedia user(s) Pmf1946, Jpg, <a href="../../../d/r/_/User%7EDr_Aaron_e0a6.html" title="User:Dr Aaron">Dr Aaron</a>, <a href="../../../e/b/m/User%7EEbmat_5a88.html" title="User:Ebmat">Ebmat</a>, <a href="../../../a/d/e/User%7EAdenosine_0f27.html" title="User:Adenosine">Adenosine</a>, <a href="../../../d/a/r/User%7EDarklilac_3c11.html" title="User:Darklilac">Darklilac</a>, <a href="../../../f/v/a/User%7EFvasconcellos_4804.html" title="User:Fvasconcellos">Fvasconcellos</a>, <a href="../../../d/r/2E/User%7EDr._Imbeau_fbc3.html" title="User:Dr. Imbeau">Dr. Imbeau</a>, <a href="../../../d/a/v/User%7EDavidruben_76a6.html" title="User:Davidruben">Davidruben</a>, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, Baysidemk, <a href="../../../a/n/d/User%7EAndrew73_a1aa.html" title="User:Andrew73">Andrew73</a>, Financeinfo, <a href="../../../h/y/d/User%7EHydro2_0b31.html" title="User:Hydro2">Hydro2</a>, <a href="../../../d/r/_/User%7EDr_Zak_7805.html" title="User:Dr Zak">Dr Zak</a>, Mercutio.Wilder, <a href="../../../n/a/w/User%7ENawlinWiki_2ff5.html" title="User:NawlinWiki">NawlinWiki</a>, <a href="../../../m/u/s/User%7EMushin_04d4.html" title="User:Mushin">Mushin</a>, <a href="../../../o/l/d/User%7EOldakQuill_3b15.html" title="User:OldakQuill">OldakQuill</a>, <a href="../../../e/d/g/User%7EEdgar181_7e9b.html" title="User:Edgar181">Edgar181</a>, <a href="../../../d/a/n/User%7EDaniel_Newby_951e.html" title="User:Daniel Newby">Daniel Newby</a>, <a href="../../../r/i/c/User%7ERichard_Arthur_Norton_%281958-_%29_421a.html" title="User:Richard Arthur Norton (1958- )">Richard Arthur Norton (1958- )</a>, <a href="../../../b/e/m/User%7EBemoeial_caf3.html" title="User:Bemoeial">Bemoeial</a> and <a href="../../../c/u/t/User%7ECutler_d4ae.html" title="User:Cutler">Cutler</a> and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
